CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
The Association between Serum Endogenous Secretory Receptor for Advanced Glycation End Products and Vertebral Fractures in Type 2 Diabetes.
Cheol Ho Lee, Min Kyung Lee, Hyun Jeong Han, Tae Ho Kim, Jae Hyuk Lee, Se Hwa Kim
Endocrinol Metab. 2012;27(4):289-294.   Published online December 20, 2012
DOI: https://doi.org/10.3803/EnM.2012.27.4.289

Excel Download

Letter: The Association between Serum Endogenous Secretory Receptor for Advanced Glycation End Products and Vertebral Fractures in Type 2 Diabetes (Endocrinol Metab 2012;27:289-94, Cheol Ho Lee et al.)
Endocrinology and Metabolism. 2013;28(1):76   Crossref logo
Link1 Link2 Link3

The Association between Serum Endogenous Secretory Receptor for Advanced Glycation End Products and Vertebral Fractures in Type 2 Diabetes
Endocrinology and Metabolism. 2012;27(4):289   Crossref logo
Link1 Link2 Link3

Response: The Association between Serum Endogenous Secretory Receptor for Advanced Glycation End Products and Vertebral Fractures in Type 2 Diabetes (Endocrinol Metab 2012;27:289-94, Cheol Ho Lee et al.)
Endocrinology and Metabolism. 2013;28(1):78   Crossref logo
Link1 Link2 Link3

Low Serum Level of the Endogenous Secretory Receptor for Advanced Glycation End Products (esRAGE) Is a Risk Factor for Prevalent Vertebral Fractures Independent of Bone Mineral Density in Patients With Type 2 Diabetes
Diabetes Care. 2009;32(12):2263-2268   Crossref logo
Link1 Link2

Association Between Serum Endogenous Secretory Receptor for Advanced Glycation End Products and Risk of Type 2 Diabetes Mellitus with Combined Depression in the Chinese Population
Diabetes Technology & Therapeutics. 2012;14(10):936-942   Crossref logo
Link1 Link2

Association Between Soluble Receptor for Advanced Glycation End Product and Endogenous Secretory Soluble Receptor for Advanced Glycation End Product Levels and Carotid Atherosclerosis in Diabetes: A Systematic Review and Meta-Analysis
Canadian Journal of Diabetes. 2021;45(7):634-640   Crossref logo
Link1 Link2

Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes
Diabetologia. 2006;49(11):2756-2762   Crossref logo
Link1 Link2 Link3

Serum Level of Endogenous Secretory Receptor for Advanced Glycation End Products and Other Factors in Type 2 Diabetic Patients With Mild Cognitive Impairment
Diabetes Care. 2011;34(12):2586-2590   Crossref logo
Link1 Link2

Tu-P10:495 Serum level of soluble receptor for advanced glycation end products is associated with circulating advanced glycation end products in type 2 diabetes
Atherosclerosis Supplements. 2006;7(3):294   Crossref logo
Link1 Link2

Reduced endogenous secretory receptor for advanced glycation end products (esRAGE) in young people with Type 1 diabetes developing microalbuminuria
Diabetic Medicine. 2009;26(8):815-819   Crossref logo
Link1 Link2